Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 6/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.33 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 2/20 | 0.32 |
| ▸ | PRCP | P42785 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6521360 | 1.00 | HTR2A (0.35) | HTR2AHTR2CHTR2BOPRM1PDPK1 | |
| SCHEMBL4290508 | 1.00 | HTR2A (0.35) | HTR2AHTR2CHTR2BOPRM1PDPK1 | |
| SCHEMBL3389204 | 0.77 | HTR2A (0.35) | HTR2AHTR2CPDPK1HRH1 | |
| SCHEMBL8890669 | 0.76 | CHRNB2 (0.33) | HTR2AOPRM1PDPK1 | |
| SCHEMBL4307808 | 0.75 | HTR2A (0.34) | HTR2AHTR2CHRH1 | |
| SCHEMBL874497 | 0.75 | HTR2A (0.34) | HTR2AHTR2CHRH1 | |
| SCHEMBL455932 | 0.75 | HTR2A (0.34) | HTR2AHTR2COPRM1HRH1 | |
| SCHEMBL458123 | 0.75 | HTR2A (0.34) | HTR2AHTR2CHRH1 | |
| SCHEMBL7883084 | 0.75 | HTR2A (0.37) | HTR2AHTR2CHTR2BHRH1 | |
| SCHEMBL8679592 | 0.75 | HTR2A (0.37) | HTR2AHTR2CHTR2BHRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1778639-A2 | ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | AMR Technology, Inc. (US) | 2007-05-02 | — | — | EP | claimed |
| WO-2006020049-A2 | ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | AMR TECHNOLOGY, INC. (US) | 2006-02-23 | — | — | WO | claimed |
| WO-1996017862-A1 | LHRH ANTAGONISTS HAVING LACTAM GROUPS AT THE N-TERMINUS | ABBOTT LABORATORIES (US) | 1996-06-13 | — | — | WO | claimed |
| EP-3045450-A1 | INTERMEDIATE COMPOUNDS IN A PROCESS FOR PRODUCING PYRIDAZINONE COMPOUNDS | SUMITOMO CHEMICAL CO., LTD. (JP) | 2016-07-20 | — | — | EP | disclosed |
| EP-2614053-A1 | METHOD FOR PRODUCING PYRIDAZINONE COMPOUNDS AND INTERMEDIATE THEREOF | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2013-07-17 | — | — | EP | disclosed |
| WO-2012033225-A1 | METHOD FOR PRODUCING PYRIDAZINONE COMPOUNDS AND INTERMEDIATE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-03-15 | — | — | WO | disclosed |
| EP-2328864-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD OF FORMING PATTERN WITH THE COMPOSITION | FUJIFILM Corporation (JP) | 2011-06-08 | — | — | EP | disclosed |
| WO-2010035905-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD OF FORMING PATTERN WITH THE COMPOSITION | FUJIFILM CORPORATION (JP) | 2010-04-01 | — | — | WO | disclosed |
| WO-2009136965-A1 | COMPOSITIONS AND METHODS COMPRISING CAPURAMYCIN ANALOGUES | SEQUELLA, INC. (US) | 2009-11-12 | — | — | WO | disclosed |
| WO-2005092882-A1 | 4-AMINO-5-HALOGENO-BENZAMIDE DERIVATIVES AS 5-HT4 RECEPTOR AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL, CNS, NEUROLOGICAL AND CARDIOVASCULAR DISORDERS | PFIZER JAPAN, INC. (JP) | 2005-10-06 | — | — | WO | disclosed |
| EP-0914354-A1 | POLYMERIZATION PROCESSES FOR OLEFINS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-05-12 | — | — | EP | disclosed |
| WO-1998003559-A1 | POLYMERIZATION PROCESSES FOR OLEFINS | E.I. DU PONT DE NEMOURS AND COMPNAY (US) | 1998-01-29 | — | — | WO | disclosed |